Conditions & Recovery · NY Times Health · November 6, 2026

Biotech Firm Claims Some Credit for Groundbreaking Virus Research

Radical Numerics turned heads with its announcement about a novel treatment. Now a former partner, Tabula Bioscience, says it performed much of the research.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Read the full story at NY Times Health ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor Understanding Breast Cancer 101 | Cancer Conversation